glp 1 sources The GLP-1 revolution: What UAB researchers are discovering about how these drugs work Something I've found really interesting...

Siebold and the other anonymous reviewer(s) for their contribution to the peer review of this work

The most common are nausea, vomiting, and diarrhea

Oral BPC-157 for Gastrointestinal Conditions Injectable BPC-157 for Musculoskeletal Conditions Injection Technique and Patient Education All patients receiving injectable BPC-157 are provided with: Detailed written instructions for reconstitution, storage, and administration In-person or video training on proper subcutaneous injection technique Sharps disposal containers and guidance on safe disposal 24-hour clinical contact for questions or concerns Most patients self-administer injections after the first week of supervised dosing

Leppik, L., Parksepp, M., Janno, S., Koido, K., Haring, L., Vasar, E., & Zilmer, M

Today, GLPs can be generally classified into 2 categories long acting (administered once weekly) or short acting (administered daily), though most remain approved only for treatment of DM

Know your source